Dabigatran etexilate

Dabigatran etexilate Reactions 1680, p109 - 2 Dec 2017 Interstitial pneumonia: case report A 73-year-old man developed interstitial pneumonia during treatment with dabigatran etexilate [dabigatran; dosage, route and time to reaction onset not stated]. The man, who had a history of paroxysmal atrial fibrillation and chronic heart failure, had been receiving anticoagulant therapy with dabigatran etexilate for 24 months. He presented with dry cough and exertional dyspnoea. On respiratory system examination, he showed fine crackles at lower back. Chest X-ray revealed lower field bilateral infiltration. Chest CT scan demonstrated ground glass opacity and non-segmental subpleural consolidation, which was consistent with nonspecific interstitial pneumonia (NSIP) with organising pneumonia (OP) pattern. He showed increased levels of KL-6, neutrophil and eosinophil without anaemia as well as autoantibodies. The man’s dabigatran etexilate therapy was discontinued, and bronchoscopy was done to check progress in his condition. Bronchoalveolar lavage fluid (BALF) was not bloody. He showed reduction in eosinophil and neutrophil levels. He also showed lymphocytes of 17.7% and CD4/CD8 ratio of 1.81 in BALF with no signs of infection. Trans-bronchial lung biopsy specimen demonstrated OP. His therapy was then switched to warfarin from dabigatran etexilate. Two months after the initiation of warfarin therapy, X-ray and Chest CT scan findings showed improvement of the previously existing opacities. Six months later, KL-6 levels returned to normal. Based on these findings, a diagnosis of dabigatran etexilate-induced interstitial pneumonia was made. Author comment: "Drug-induced lung injury is diagnosed on the basis of clinical examination and radiographic and histological findings". "Cases that develop subacutely, as in the present case, tend to be [nonspecific interstitial pneumonia] or [organising pneumonia]." "Therefore, the patient’s interstitial pneumonia was diagnosed to be a drug- induced lung injury caused by dabigatran." Yanagihara T, et al. Interstitial pneumonia caused by dabigatran. Respiratory Medicine Case Reports 23: 10-12, Jan 2018. Available from: URL: http:// doi.org/10.1016/j.rmcr.2017.10.009 - Japan 803284578 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Dabigatran etexilate

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial